Urban Sky
United States
- Denver
- 17/10/2023
- Series A
- $9,750,000
Urban Sky's novel invention, the high-altitude Microballoon™, leverages advances in component miniaturization and first-of-its-kind material re-usability to drastically reduce the cost of high-resolution remote sensing over broad, targeted areas, leading to more impactful data over more areas than ever before.
The Microballoon™ is the first ever reusable stratospheric balloon. It's also the first ever precisely placeable remote sensing balloon. The Microballoon™ has a unique ability to image specific areas at desired times, never before possible with stratospheric balloons. This capability is made possible by coupling advanced balloon design with a very small form factor, enabling launch from virtually anywhere at any time with minimal personnel and equipment required. The Microballoon is also zero-emission, making it the most sustainable way to image Planet Earth.
Remote sensing from the stratosphere combines many of the benefits of both space-based assets and lower altitude airborne vehicles. That means remote sensing data can be collected from the Stratosphere over vast areas, with aerial quality-resolution, at the lowest possible cost. This unique combination of advantages will finally unlock the full commercial usefulness of the Stratosphere.
- Industry Aviation and Aerospace Component Manufacturing
- Website https://www.urbansky.com/
- LinkedIn https://www.linkedin.com/company/urban-sky-imaging/about/
Maritime Fusion | $4,500,000 | (Nov 25, 2025)
Opti | $20,000,000 | (Nov 25, 2025)
Cordance Medical | $8,000,000 | (Nov 25, 2025)
AI One | $7,000,000 | (Nov 25, 2025)
Redrob | $10,000,000 | (Nov 25, 2025)
Pibit.AI | $7,000,000 | (Nov 25, 2025)
Votre | $3,750,000 | (Nov 25, 2025)
Tidalwave | $22,000,000 | (Nov 25, 2025)
Relixir | $2,000,000 | (Nov 25, 2025)
Interface | $3,500,000 | (Nov 25, 2025)
Model ML | $75,000,000 | (Nov 25, 2025)
Mirantus Health | $6,338,062 | (Nov 25, 2025)